Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60…
The company’s latest funding round includes investments from Alkeon Capital, B Capital Group, BlackRock Private Equity Partners, Tiger Global, Insight…